PLA2G2A and colonic neoplasm: For example, PLA2G2A was only identified to be associated with hsa−mir−129−1 in stage I, and was previously reported to have low expression in colon cancer patients [49] and hsa−mir−129−1 was reported to act as a tumor suppressor [50].